|
|
LTBS Scientific Advisory Committee
| Chairperson | Paul B. Watkins, MD, Chairman of the DILIN Steering Committee and Professor of Medicine at the University of North Carolina. | | CRADA Representatives | Frederick A. Beland, PhD, Director, Division of Biochemical Toxicology
Pieter Muntendam, MD, CEO, BG Medicine | | CDER | John R. Senior, M.D. Associate Director for Science, Office of Pharmacoepidemiology and Statistical Science and former President of AASLD | | External Advisor | Neil Kaplowitz, MD, Professor of Medicine at the University of Southern California and Former President of AASLD | | Members: | Robert McBurney PhD, Sr VP & CSO, BG Medicine
One representative per participating pharmaceutical company |

|